BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  Smart Insulin Tech Helps Pregnant Women with Type 1 Diabetes Maintain Target Blood Glucose Levels

  June 23, 2025

   · 

  4 min read
• Press Releases

  OrsoBio to Present Preclinical Data on Mitochondrial Protonophore Portfolio in Models of Obesity at the American Diabetes Association’s 85th Scientific Sessions

  June 23, 2025

   · 

  6 min read
• Press Releases

  Enzon and Viskase Enter into Merger Agreement

  June 23, 2025

   · 

  10 min read
• Press Releases

  CCS Presents Four Peer-Reviewed Posters at American Diabetes Association’s 85th Scientific Sessions

  June 23, 2025

   · 

  4 min read
• Press Releases

  Lilly’s oral GLP-1, orforglipron, showed compelling efficacy and a safety profile consistent with injectable GLP-1 medicines, in complete Phase 3 results published in The New England Journal of Medicine

  June 23, 2025

   · 

  11 min read
• Press Releases

  Semaglutide Increases Walking Capacity in Patients with Peripheral Artery Disease and Type 2 Diabetes

  June 23, 2025

   · 

  4 min read
• Press Releases

  Sciwind Biosciences Announces Publication of Phase III SLIMMER Trial Results in The Lancet Diabetes & Endocrinology and Oral Presentation at ADA Scientific Sessions

  June 23, 2025

   · 

  1 min read
• Press Releases

  Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine

  June 23, 2025

   · 

  8 min read
• Press Releases

  Novo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data presented at the ISTH 2025 Congress

  June 23, 2025

   · 

  9 min read
• Press Releases

  Exelixis Announces Zanzalintinib in Combination with an Immune Checkpoint Inhibitor Improved Overall Survival in STELLAR-303 Phase 3 Pivotal Trial in Patients with Metastatic Colorectal Cancer

  June 23, 2025

   · 

  7 min read